224 related articles for article (PubMed ID: 18840072)
1. Molecular pathogenesis and diagnostics of bladder cancer.
Mitra AP; Cote RJ
Annu Rev Pathol; 2009; 4():251-85. PubMed ID: 18840072
[TBL] [Abstract][Full Text] [Related]
2. In search of the perfect crystal ball for Ta urothelial cancer.
Chin JL
Eur Urol; 2010 Jan; 57(1):21-2; discussion 23-4. PubMed ID: 19748172
[No Abstract] [Full Text] [Related]
3. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
[TBL] [Abstract][Full Text] [Related]
4. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM
Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741
[TBL] [Abstract][Full Text] [Related]
5. Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy.
Denzinger S; Stoehr R; Schwarz S; Eichenseher N; Brockhoff G; Obermann EC; Knuechel R; Blaszyk H; Hartmann A; Wild PJ
Int J Oncol; 2007 Oct; 31(4):793-802. PubMed ID: 17786310
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of bladder cancer: targets for diagnosis and therapy.
Baffa R; Letko J; McClung C; LeNoir J; Vecchione A; Gomella LG
J Exp Clin Cancer Res; 2006 Jun; 25(2):145-60. PubMed ID: 16918124
[TBL] [Abstract][Full Text] [Related]
7. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
[TBL] [Abstract][Full Text] [Related]
8. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A
Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538
[TBL] [Abstract][Full Text] [Related]
9. ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology.
Amin MB; McKenney JK; Paner GP; Hansel DE; Grignon DJ; Montironi R; Lin O; Jorda M; Jenkins LC; Soloway M; Epstein JI; Reuter VE;
Eur Urol; 2013 Jan; 63(1):16-35. PubMed ID: 23083804
[TBL] [Abstract][Full Text] [Related]
10. Novel biomarkers to predict response and prognosis in localized bladder cancer.
Lucca I; de Martino M; Klatte T; Shariat SF
Urol Clin North Am; 2015 May; 42(2):225-33, ix. PubMed ID: 25882564
[TBL] [Abstract][Full Text] [Related]
11. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.
Gabriel U; Li L; Bolenz C; Steidler A; Kränzlin B; Saile M; Gretz N; Trojan L; Michel MS
Mol Carcinog; 2012 Nov; 51(11):907-15. PubMed ID: 21976419
[TBL] [Abstract][Full Text] [Related]
12. Utility of diagnostic and prognostic markers in urothelial carcinoma of the bladder.
Coleman JF; Hansel DE
Adv Anat Pathol; 2009 Mar; 16(2):67-78. PubMed ID: 19550368
[TBL] [Abstract][Full Text] [Related]
13. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling.
van der Kwast TH; Bapat B
Curr Opin Urol; 2009 Sep; 19(5):516-21. PubMed ID: 19553819
[TBL] [Abstract][Full Text] [Related]
14. [Role of Ki-67, mutated gene-suppressor p53 and HER-2neu oncoprotein in the prognosis for the clinical course of bladder cancer].
Masliukova EA; Pozharisskiĭ KM; Karelin MI; Startsev VIu; Ten VP
Vopr Onkol; 2006; 52(6):643-8. PubMed ID: 17338241
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment on: Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
Kruck S; Sievert KD
Eur Urol; 2009 Nov; 56(5):845-6. PubMed ID: 18945542
[No Abstract] [Full Text] [Related]
16. Editorial comment on: Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
Montironi R; Scarpelli M; Lopez-Beltran A; Cheng L
Eur Urol; 2009 Nov; 56(5):846-7. PubMed ID: 18945536
[No Abstract] [Full Text] [Related]
17. Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.
Munari E; Fujita K; Faraj S; Chaux A; Gonzalez-Roibon N; Hicks J; Meeker A; Nonomura N; Netto GJ
Hum Pathol; 2013 Dec; 44(12):2668-76. PubMed ID: 24074531
[TBL] [Abstract][Full Text] [Related]
18. [Update on FGFR3 mutation and multiple regional epigenetic silencing (MRES) phenotype in urothelial carcinogenesis].
Masson-Lecomte A; Vordos D; de la Taille A; Neuzillet Y; Radvanyi F; Allory Y
Prog Urol; 2013 Feb; 23(2):96-8. PubMed ID: 23352301
[TBL] [Abstract][Full Text] [Related]
19. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation.
Zhang ZT; Pak J; Huang HY; Shapiro E; Sun TT; Pellicer A; Wu XR
Oncogene; 2001 Apr; 20(16):1973-80. PubMed ID: 11360181
[TBL] [Abstract][Full Text] [Related]
20. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]